Sector dividends Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.71 USD | +0.64% |
|
-27.13% | +0.19% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | -9.43x | - | - | - | - | 1.32B | |
| 0.97% | 1.12% | 32.97x | 4.39x | 5.89x | 17.53x | 24.65x | 48.57B | |
| -.--% | -.--% | -24.62x | 19.31x | 371.2x | -22.67x | -22.59x | 41.95B | |
| -.--% | -.--% | 30.4x | 5.55x | 3.03x | 13.06x | 19.73x | 38.85B | |
| -.--% | -.--% | 47.04x | 7.12x | 4.9x | 30.42x | 30.86x | 37.24B | |
| 0.4% | 0.43% | 28.96x | 2.35x | 8.37x | 21.04x | 25.06x | 30.67B | |
| -.--% | -.--% | 33.42x | 23.98x | 5.47x | 24.86x | 26.01x | 16.41B | |
| 1.16% | 1.32% | 23.18x | 2.6x | 2.03x | 8.81x | 13.5x | 13.97B | |
| -.--% | -.--% | 27.7x | 1.32x | 1.86x | 11.42x | 13.01x | 12.62B | |
| -.--% | -.--% | 52.88x | 4.06x | 3.76x | 14.71x | 18.08x | 12.56B | |
| 0.44% | 0.44% | 60.5x | 5.17x | 9.23x | 26.22x | 28.64x | 11.22B | |
| -.--% | -.--% | -30.76x | 9.05x | 110.81x | -31.54x | -54.89x | 10.86B | |
| -.--% | -.--% | -31.1x | 9x | 1000.82x | -26.53x | -26x | 10.08B | |
| 0.61% | 0.72% | 37.24x | 4.1x | 4.32x | 18.5x | 28.3x | 9.86B | |
| -.--% | -.--% | -15.16x | 627.34x | 9.35x | -15.35x | -14.6x | 9.01B | |
| -.--% | -.--% | -21x | 7.95x | 3606.23x | -17.72x | -17.26x | 8.9B | |
| -.--% | -.--% | 32.33x | - | 15.58x | 28.89x | 29.06x | 8.83B | |
| -.--% | -.--% | -27.82x | 7.8x | 69.13x | -19.45x | -17.12x | 8.68B | |
| -.--% | 0.45% | 19.93x | 2.29x | 4.34x | 11.42x | 14.87x | 8.68B | |
| Average | 0.2% | 0.25% | 14.03x | 43.73x | 290.91x | 5.20x | 6.63x | 17.91B | |
| Weighted average by Cap. | 0.26% | 0.3% | 19.26x | 24.75x | 179.95x | 8.27x | 10.72x |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
